Related by context. All words. (Click for frequent words.) 73 Amrubicin 72 alvespimycin 72 EOquin TM 71 Plenaxis TM 71 ruxolitinib 71 YONDELIS 71 Azedra 71 MAGE A3 ASCI 70 Troxatyl 70 lumiliximab 70 HuMax CD4 70 Pradefovir 70 phase IIb clinical 69 anticancer compound 69 sorafenib Nexavar 69 BAY #-# 69 ONTAK 69 apaziquone 69 ATL# [001] 69 phase IIa clinical 69 Proxinium TM 69 tanespimycin 69 INC# 69 Cloretazine 69 radiation sensitizer 69 Panzem R NCD 69 Bezielle 69 oral ridaforolimus 69 PNP inhibitor 69 ularitide 69 AQ4N 69 Mipomersen 69 forodesine 69 alvimopan 69 elotuzumab 69 Traficet EN 69 Phase Ib study 69 OvaRex ® MAb 69 LEUKINE 69 Marqibo 69 forodesine hydrochloride 68 methylnaltrexone 68 EFAPROXYN 68 Archexin 68 receptor tyrosine kinase inhibitor 68 JAK inhibitor 68 Dapagliflozin 68 Xanafide 68 oral prodrug 68 octreotide implant 68 UPLYSO 68 TELCYTA 68 Seliciclib 68 romidepsin 68 AEG# 68 HuLuc# 68 TBC# 68 mapatumumab 68 Icatibant 68 lintuzumab 68 Tarceva TM 68 OPAXIO 68 PDE4 inhibitor 68 Zolinza 68 Onco TCS 68 Loramyc R 68 Sym# 68 blinatumomab 67 CCR5 antagonist 67 Plicera 67 Raptiva ® 67 Dacogen injection 67 PSN# [002] 67 PrevOnco 67 CCX# 67 Elagolix 67 Annamycin 67 Velcade bortezomib 67 veltuzumab 67 teduglutide 67 vidofludimus 67 Clevudine 67 Bicifadine 67 HGS# 67 Urocidin TM 67 Reverset 67 PS# [001] 67 Cloretazine ® 67 TELINTRA 67 Chemophase 67 docetaxel Taxotere ® 67 Phenoptin 67 INCB# [002] 67 HGS ETR1 67 Cleviprex TM clevidipine 67 PANVAC VF 67 Ceflatonin 67 OncoVEX GM CSF 67 Ozarelix 67 ISTODAX 67 Panzem R 67 Zybrestat 67 fenofibric acid 67 Fibrillex TM 67 nucleoside analog 67 Evoltra ® 67 PREOS R 67 CEQ# 67 RhuDex ® 67 PROMACTA 67 Irinotecan 67 AZILECT ® 67 PSMA ADC 67 Onconase 67 SNT MC# 67 Dyloject TM 67 Silodosin 67 Gabapentin GR 67 TEMODAL 67 ALGRX 67 pradefovir 67 cell lymphoma CTCL 67 Nexavar sorafenib 67 generation purine nucleoside 67 Degarelix 67 Tyrima 67 Cellegesic 67 Fodosine 67 micafungin 67 RAPAFLO 67 amrubicin 67 PF # [001] 66 Nexavar ® 66 pitavastatin 66 silodosin 66 Aplidin 66 obatoclax 66 ganetespib 66 posaconazole 66 ELACYT 66 Iluvien ® 66 refractory chronic lymphocytic 66 TYZEKA 66 TOCOSOL Paclitaxel 66 SILENOR 66 INT# [002] 66 Peginterferon alfa 2b 66 INCB# [001] 66 Amplimexon 66 INCB# [003] 66 phase IIb trial 66 Amigal 66 ixabepilone 66 PEP# [003] 66 CHOP chemotherapy 66 CYT# potent vascular disrupting 66 Excellarate 66 Targretin capsules 66 tezampanel 66 mertansine 66 AGGRASTAT ® 66 KRN# 66 BeneFIX 66 rNAPc2 66 Allovectin 7 66 PHX# 66 valopicitabine 66 trabectedin 66 fosbretabulin 66 IL# PE#QQR 66 sitaxsentan 66 regorafenib 66 Evoltra 66 ENMD # 66 oral methylnaltrexone 66 DAVANAT 66 XmAb# 66 sunitinib malate 66 abiraterone acetate 66 dextromethorphan quinidine 66 herpetic keratitis 66 Phase 2b clinical 66 AeroLEF TM 66 Phase #b/#a trial 66 Darusentan 66 Proquin XR 66 R#/MEM # 66 histone deacetylase HDAC inhibitor 66 HER2 positive metastatic breast 66 Ambrisentan 66 bendamustine 66 daclizumab 66 Teysuno 66 refractory AML 66 cangrelor 66 Phase IIb clinical trials 66 proteasome inhibitor 66 Romidepsin 66 trastuzumab Herceptin ® 66 EndoTAG TM -1 66 MGCD# [001] 66 DDP# 66 BRIM2 66 HuMax CD# 66 Phase #b/#a 66 CDK inhibitor 66 ATL/TV# 66 #D#C# 66 CINTREDEKIN BESUDOTOX 66 MEK inhibitors 66 relapsed MM 66 pertuzumab 66 ARIKACE 66 vascular disrupting agents 66 dacetuzumab 66 liposomal formulation 66 rALLy trial 66 Cloretazine R VNP#M 66 enzastaurin 66 IMA# 66 OvaRex R 66 diabetic neuropathic pain 66 erlotinib Tarceva ® 66 StemEx 66 Phase #b/#a clinical 66 metastatic renal cell carcinoma 66 thymalfasin 66 Clolar ® 66 IRESSA 65 EGS# 65 selective modulator 65 relapsed multiple myeloma 65 Alzhemed TM 65 BrachySil 65 Aptivus ® 65 miconazole Lauriad ® 65 Phase IIIb clinical 65 metaglidasen 65 IMC #B 65 sargramostim 65 Ophena TM 65 PEGylated anti 65 KNS # 65 Aflibercept 65 Zingo TM 65 dasatinib Sprycel ® 65 acyclovir Lauriad R 65 Ventavis 65 atacicept 65 thalidomide Thalomid 65 AP# [003] 65 PDX pralatrexate 65 IMGN# 65 Vicinium TM 65 cutaneous T cell 65 Aurexis 65 Guanilib 65 zanolimumab 65 Blinatumomab 65 OXi# 65 FOLOTYN ® 65 Myocet 65 HuMax EGFr 65 Firazyr 65 orBec 65 Tamibarotene 65 Alocrest 65 Phase III randomized controlled 65 ZACTIMA 65 selective androgen receptor modulator 65 Cetrorelix 65 OMP #M# 65 PrevOnco ™ 65 registrational trial 65 epothilone 65 Targretin 65 Civacir 65 Phase Ib 65 BEXXAR 65 Actimmune ® 65 Onalta ™ 65 Pimavanserin 65 pomalidomide 65 Leukine ® 65 Phase Ib clinical 65 CIMZIA ™ 65 Genasense ® 65 MEK inhibitor 65 BAL# [002] 65 MyVax R 65 PRT# 65 mGluR5 NAM 65 PRX# 65 MabCampath 65 dasatinib Sprycel 65 ALN PCS 65 Telintra 65 Phase 2b trial 65 elagolix 65 dextofisopam 65 AZILECT R 65 Fludara ® 65 Safinamide 65 BrachySil TM 65 MGd 65 Onalta 65 Specifid 65 lapatinib Tykerb 65 neratinib 65 Gefitinib 65 UVIDEM 65 Pazopanib 65 JAK1 65 Raptiva R 65 MYDICAR ® 65 Virulizin R 65 trospium 65 TREANDA 65 brivaracetam 65 Aclidinium 65 tubulin inhibitor 65 refractory CLL 65 gefitinib Iressa 65 BLA filing 65 Allovectin 7 ® 65 Zenvia ™ 65 HGS ETR2 65 PI3K/Akt pathway inhibitor 65 intranasal formulation 65 MOZOBIL 65 orally administered inhibitor 65 ofatumumab HuMax CD# 65 Voreloxin 65 Erlotinib 65 CD# antibody [001] 65 Syncria 65 Onrigin 65 cetuximab Erbitux ® 65 cinacalcet HCl 65 Erbitux cetuximab 65 pharmacokinetic PK study 65 omacetaxine mepesuccinate 65 Aloxi injection 65 bevacizumab Avastin ® 65 PEG SN# 65 TRISENOX ® 65 Phase IIa trials 65 vandetanib 65 Dasatinib 65 LY# [003] 65 Phase 2b study 65 Stedivaze 65 Virulizin ® 65 VALSTAR 65 standard chemotherapy regimen 65 PXD# 65 adenosine injection 65 Gemzar ® 65 Fludara 65 ponatinib 65 Tanespimycin 65 Phase 2a trial 65 TRISENOX 65 ADVEXIN 65 tafamidis 65 Epratuzumab 65 tesmilifene 65 GRN# 65 Neurodex 65 subcutaneous formulation 65 Q#IR 65 axitinib 65 Dalbavancin 65 TG# [003] 65 bicifadine 65 Phase #/#a trial 65 Elitek 65 maribavir 65 palonosetron 65 lomitapide 65 Spiegelmer ® 65 Treanda 65 tamibarotene 65 GALNS 65 ritonavir boosted 65 evaluating tivozanib 65 INTEGRILIN 64 Vidaza azacitidine 64 LEP ETU 64 PREOS 64 VNP#M 64 LHRH antagonist 64 CR# vcMMAE 64 fluoropyrimidine 64 HCV protease inhibitor 64 Eraxis 64 mTOR inhibitor 64 GLP toxicology studies 64 goserelin 64 Azedra TM 64 registrational 64 prGCD 64 vinorelbine 64 Bortezomib 64 EDEMA3 64 DOXIL 64 BENICAR HCT 64 Relivar 64 Capesaris 64 castrate resistant prostate cancer 64 NXL# 64 Aurora kinase 64 AEGR 64 TAFA# 64 trastuzumab DM1 T DM1 64 TKM ApoB 64 Radezolid 64 NOXAFIL 64 MoxDuo IR 64 SUTENT 64 Removab 64 Omigard 64 R sorafenib tablets 64 GATTEX ® 64 paclitaxel Taxol R 64 CANCIDAS 64 visilizumab 64 elvucitabine 64 TLK# 64 TYKERB 64 Laquinimod 64 RLY# 64 CAPHOSOL 64 favorable pharmacokinetic profile 64 superficial bladder cancer 64 Pemetrexed 64 Tekturna HCT 64 tipranavir 64 Pafuramidine 64 seliciclib CYC# 64 Solazed 64 reslizumab 64 TheraCIM 64 humanized anti 64 Increlex ® 64 albinterferon alfa 2b 64 CIMZIA TM 64 metastatic hormone refractory 64 SinuNase TM 64 HepeX B 64 Plenaxis R 64 Gliadel Wafer 64 DPP4 64 Lubiprostone 64 Symadex 64 IMC A# 64 APTIVUS 64 SinuNase 64 biologic therapy 64 hormone LHRH antagonist 64 casopitant 64 Phase IIa trial 64 tigecycline 64 Rebif ® 64 Personalized Immunotherapy 64 LymphoStat B belimumab 64 Fulvestrant 64 Ixempra 64 decitabine 64 diarrhea predominant irritable 64 ALK inhibitor 64 Atrasentan 64 relapsed refractory multiple myeloma 64 glucokinase activator 64 PLK1 SNALP 64 telaprevir dosed 64 AMEVIVE 64 VA# [002] 64 THALOMID 64 Nimotuzumab 64 oral talactoferrin 64 Nanobody 64 MOVIPREP R 64 plasma kallikrein inhibitor 64 efalizumab 64 myelofibrosis polycythemia vera 64 dirucotide 64 microtubule inhibitor 64 confirmatory Phase III 64 Intravenous CP 64 Allovectin 7 R 64 bortezomib Velcade R 64 BCR ABL inhibitor 64 Onbrez Breezhaler 64 OMNARIS HFA 64 Urocidin 64 IAP inhibitor 64 ofatumumab 64 Arranon 64 preclinically 64 eniluracil 64 ORENCIA ® 64 belinostat 64 Vidofludimus 64 pediatric acute lymphoblastic 64 MAA submission 64 palifermin 64 cutaneous T 64 mRCC 64 Lixivaptan 64 HCV protease inhibitors 64 aleglitazar 64 selective estrogen receptor modulator 64 Hycamtin 64 Zarnestra 64 combretastatin A4 phosphate CA4P 64 PSN# [001] 64 huC# DM4 64 refractory prostate cancer 64 Levetiracetam 64 tramiprosate Alzhemed TM 64 Saxagliptin 64 Factor VIIa 64 terlipressin 64 cetrorelix 64 luteinizing hormone releasing 64 anidulafungin 64 ATryn ® 64 Taxol paclitaxel 64 Zerenex 64 novel VDA molecule 64 CA4P 64 INTEGRILIN ® 64 YONDELIS R 64 Zirgan 64 SEBIVO 64 bazedoxifene 64 oral Xeloda 64 Cloretazine VNP#M 64 cannabinor 64 Vorinostat 64 NGX# 64 CRMD# 64 methylnaltrexone bromide 64 Lenalidomide 64 Soliris TM eculizumab 64 drug ISA# 64 TNF Tumor Necrosis Factor 64 Eltrombopag 64 ATPace TM 64 Vectibix panitumumab 64 Thalomid ® 64 COMFORT II 64 GW# [003] 64 Besivance 64 Prosaptide 64 sorafenib tablets 64 histamine dihydrochloride 64 pralatrexate 64 zileuton 64 Omacetaxine 64 aflibercept 64 oral taxane 64 Sutent sunitinib 64 targeted radiotherapeutic 64 Trofex 64 FIRMAGON 64 R roscovitine 64 orally bioavailable 64 ZOLINZA 64 ApoB SNALP 64 BCX# 64 torezolid phosphate 64 CDP# 64 NUVIGIL 64 TRC# 64 teriflunomide 64 CINOD 64 Denufosol 64 Sprycel dasatinib 64 CB2 selective receptor agonist 64 Insegia 64 G#DT 64 AzaSite Plus 64 Increlex R 64 Aptivus 64 OHR/AVR# 64 Octreolin 64 Cytoxan 64 candesartan cilexetil 64 rilonacept 64 DermaVir Patch 64 Phase 1a clinical 64 beta 1a 64 Nuvion 64 AZD# 64 Gleevec imatinib mesylate 64 calcineurin inhibitors 64 phase IIb study 64 HQK 64 TREDAPTIVE 64 pharmacodynamic PD 64 Orazol 64 farletuzumab 64 Apoptone 64 Emselex 63 renin inhibitor 63 Hexvix 63 dalbavancin 63 bortezomib Velcade 63 Topotecan 63 trastuzumab DM1 63 cancer neuroendocrine tumor 63 TELCYTA TM TLK# 63 TYGACIL 63 tramiprosate 63 IV Busulfex 63 indibulin 63 QuadraSphere 63 ALVESCO R 63 GnRH antagonist 63 telbivudine 63 6R BH4 63 Vandetanib 63 PD LID 63 eprotirome 63 azacitidine 63 CD3 monoclonal antibody 63 malignant ascites 63 incyclinide 63 inhibitor RG# 63 Squalamine 63 Ixabepilone 63 cancer immunotherapies 63 Mepact 63 Phase IIb trials 63 eltrombopag 63 L BLP# 63 Polymer Microspheres 63 Triolex 63 ACEON R 63 clofarabine 63 HERCEPTIN 63 FUSILEV ® 63 Durezol 63 abatacept Orencia 63 nucleoside analogue 63 elacytarabine 63 docetaxel chemotherapy 63 Dacogen decitabine 63 dose cohort 63 Soliris eculizumab 63 docetaxel Taxotere R 63 ALN TTR 63 galiximab 63 Candesartan 63 Asentar 63 IAP inhibitors 63 INTELENCE 63 inhaled AAT 63 RH1 63 talactoferrin 63 tivozanib 63 budesonide foam 63 Advagraf 63 severe hypercholesterolemia 63 celgosivir 63 Cloretazine R 63 vascular disrupting agent 63 Vernakalant 63 bevacizumab Avastin 63 SILENOR TM 63 ITAX 63 acyclovir Lauriad ® 63 ATD Gel 63 ATL# [002] 63 NVA# 63 HIV integrase inhibitor 63 Mylotarg 63 VAPRISOL 63 atrasentan 63 subcutaneously administered 63 Revlimid lenalidomide 63 Zebinix R 63 sodium glucose cotransporter 63 Cinryze ™ 63 IRX 2 63 Indaflex TM 63 Phase III clinical 63 multicenter Phase III 63 Luteinizing Hormone Releasing Hormone 63 TPI ASM8 63 Panzem 63 Granisetron 63 Pyridorin 63 PROVENGE sipuleucel T 63 GSK# [001] 63 DOS# 63 oropharyngeal candidiasis 63 NEBIDO 63 refractory indolent non 63 Zemiva ™ 63 Hyphanox 63 PROVIGIL 63 CORT # 63 rALLy 63 RSD# 63 Arcalyst 63 boosted protease inhibitor 63 Dextofisopam 63 5 HT3 antagonist 63 Ocrelizumab 63 Telavancin 63 satraplatin 63 nalbuphine ER 63 TORISEL 63 PNT# 63 riociguat 63 Sanofi Aventis Taxotere 63 effector function 63 Herceptin trastuzumab 63 MAP# 63 noninfectious uveitis 63 Trastuzumab 63 Ecallantide 63 canakinumab 63 Telbivudine 63 Aplidin R 63 JANUVIA 63 BioNumerik 63 CoFactor 63 ORENCIA R 63 cisplatin gemcitabine 63 IV APAP 63 ozarelix 63 Phase 2a clinical 63 BCR ABL inhibitors 63 Pertuzumab 63 demonstrated antitumor activity 63 EDEMA4 63 LibiGel ® 63 Corlux 63 mitomycin 63 glatiramer acetate 63 Zemplar Capsules 63 VIMOVO 63 EPC# 63 Aurora kinase inhibitor 63 FOLOTYN 63 pharmacodynamic properties 63 leukemia CLL 63 phase Ib 63 polymerase inhibitor 63 TMC# [002] 63 TRIOLEX 63 Azacitidine 63 AVASTIN 63 Darunavir 63 Androxal TM 63 RAV# 63 VPRIV 63 GRNVAC1 63 Xibrom TM 63 brentuximab vedotin SGN 63 Alvesco R 63 OncoVEX 63 inhaled liposomal ciprofloxacin 63 biologic DMARD 63 Cannabinor 63 Mycamine 63 Phase 2a 63 FUSILEV 63 HuMax 63 temsirolimus 63 Daclizumab 63 Fibrin Pad 63 Gleevec Glivec 63 Inhalation Solution 63 TH# [003] 63 castration resistant prostate cancer 63 pegylated liposomal doxorubicin 63 Noxafil 63 Cardio Vascu Grow 63 liposomal amphotericin B 63 liposomal doxorubicin 63 HCD# [002] 63 CCR5 inhibitor 63 Quinamed 63 VELCADE melphalan 63 rALLy clinical trial 63 DB# [003] 63 FASLODEX 63 alefacept 63 lesinurad 63 Difimicin 63 Bendamustine 63 ELIQUIS 63 oral deforolimus 63 SUPPRELIN R LA 63 phase IIb 63 low dose cytarabine 63 pan HDAC inhibitor 63 vicriviroc 63 HepaSphere 63 TRO# 63 Phase Ib II 63 otelixizumab 63 concurrent chemoradiation 63 cediranib 63 AGGRASTAT R 63 desvenlafaxine 63 CAELYX 63 T#I [002] 63 Huntexil 63 Onrigin TM 63 Navelbine ® 63 ISENTRESS 63 pseudobulbar affect PBA 63 vorinostat 63 trastuzumab Herceptin R 63 non nucleoside inhibitor 63 Epanova 63 Torisel 63 Sapacitabine 63 Taxotere R 63 Stimuvax R 63 pegylated interferon alfa 63 nucleoside reverse transcriptase inhibitor 63 Phase III 63 rhMBL 63 fesoterodine 63 octreotide acetate 63 Temsirolimus 63 Xyrem ® 63 Avastin bevacizumab 63 rufinamide 63 pegfilgrastim 63 ThermoDox R 63 diclofenac sodium 63 PGL# 63 Kepivance 63 Sudhir Agrawal D.Phil 63 SUTENT ® 63 LB# [003] 63 Campath ® 63 pain palliation 63 INKP 63 depsipeptide 63 Evamist TM 63 Ridaforolimus 63 FavId 63 piperacillin tazobactam 63 volociximab 63 PEGPH# 63 Hycamtin ® 63 MAXY G# 63 imatinib mesylate 63 DEB# 63 CLIRS trial 63 Anturol ® 63 LHRH antagonists 63 Everolimus 63 Orphan Drug designations 63 bosutinib 63 ToGA 63 PEGylated interferon 63 Gleevec resistant 63 Phase IIa clinical 63 faropenem 63 Triapine R 63 HoFH 63 huN# DM1 63 olaparib 63 caspofungin 63 RITUXAN 63 CLORETAZINE TM VNP#M 62 Aryplase 62 oral salmon calcitonin 62 novel histone deacetylase 62 Aurora Kinase 62 EGFR tyrosine kinase inhibitors 62 ZYBRESTAT 62 Zenpep 62 PRX # 62 immunotherapeutic agent 62 pancreatic enzyme replacement 62 Lucanix R 62 Glufosfamide 62 PEG PAL 62 cytostatic 62 Ereska 62 carcinoid syndrome 62 Dabigatran etexilate 62 opioid induced bowel dysfunction 62 Hsp# Inhibitor 62 peripherally acting 62 Anticalin R 62 cetuximab Erbitux R 62 Phase IIB 62 humanized monoclonal antibody 62 AAG geldanamycin analog 62 ADP receptor antagonist 62 vosaroxin 62 ocrelizumab 62 Proellex TM 62 odanacatib 62 Iluvien TM 62 oncolytic vaccine 62 myelodysplastic myeloproliferative diseases 62 ELND# 62 Akt inhibitor 62 HDACi 62 SERMs 62 XL# XL# 62 registrational studies 62 indolent NHL 62 trastuzumab Herceptin 62 alkylating agent 62 topical antifungal 62 ALTACE 62 CBLC# 62 Tasigna nilotinib 62 Itopride 62 highly selective adenosine 62 albiglutide 62 DEXILANT 62 BEMA TM Fentanyl 62 oxaliplatin Eloxatin 62 Vaprisol 62 XL# XL# XL# XL# 62 Diamyd ® 62 Combidex 62 vemurafenib 62 APTIVUS r 62 lexidronam injection 62 ospemifene 62 MYCAMINE 62 marketed pegylated interferons 62 somatostatin analogue 62 Nebido 62 REOLYSIN ® 62 Genz # 62 Aviptadil 62 ezogabine 62 oral anticoagulant 62 orphan medicinal product 62 fostamatinib 62 SCCHN 62 dosage regimens 62 GAMMAGARD 62 GAP #B# 62 Vicriviroc 62 dosing cohort 62 Cimzia TM 62 glufosfamide 62 Arimidex anastrozole 62 ARIKACE ™ 62 recurrent glioblastoma multiforme 62 idarubicin 62 REMUNE R 62 oral rivaroxaban 62 FIRMAGON R 62 Fibrillex 62 oral iron chelator 62 Ranolazine 62 tosedostat 62 oxybutynin gel 62 virus HCV protease inhibitor 62 metastatic malignant 62 crizotinib PF # 62 Atiprimod 62 Inhalation Aerosol 62 SAR# [004] 62 PI3K inhibitor 62 Abiraterone acetate 62 Clolar 62 Phase III clinical trials 62 imatinib Gleevec ® 62 octreotide 62 DXL# 62 Hedgehog Pathway Inhibitor 62 VEGF inhibitors 62 ADAGIO study 62 2 methoxyestradiol 62 Solazed TM 62 Pivotal Phase III 62 denileukin diftitox 62 orally dosed 62 interferon gamma 1b 62 squalamine 62 entinostat 62 K ras mutations 62 Xeloda ® 62 IND submission 62 Phase IIIb 62 Maribavir 62 xanthine oxidase inhibitor 62 ZYFLO 62 protein kinase inhibitor